My Name is Raj Sinha, new joinee on this forum. I have been involved in the Clinical Trials conduct for a long time. I am quite familiar with CDISC, MeDRA, WHODrug and such standards/vocabularies. But now expanding to the real-world data and interested to learn from this wonderful community.
With COVID, the travel data seem to be an important piece of information. It can help contact-tracing, help predict likelihood of infection, and could be a key factor for insurance decision making. Does OMOP CDM has anyway of capturing this data or is there a way the model can be extended for capturing such data points?